Study to Assess the Safety, Tolerability, and Pharmacokinetics of E2082 in Healthy Male Subjects
Clinical trial NCT03402178 · TERMINATED
Trial details
- NCT number
- NCT03402178
- Sponsor
- Eisai Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-21
- Primary completion
- 2020-02-20
- Enrollment
- 118
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.